Acute liver failure

Annals of Hepatology

Volumn 9, Issue 1, 2010, Pages 7-14

  Pathikonda, Murali ^a   Munoz, Santiago J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetaminophen liver injury; Acute liver failure; Cerebral edema; Fulminant liver failure; Hepatic encephalopathy; Hepatitis

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ACICLOVIR; AMPICILLIN; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; BARBITURIC ACID DERIVATIVE; BLOOD CLOTTING FACTOR 7; CEPHALOSPORIN; FELBAMATE; HALOTHANE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYPERTENSIVE AGENT; ISONIAZID; KETOCONAZOLE; LACTULOSE; LAMOTRIGINE; MANNITOL; NUCLEOSIDE ANALOG; PARACETAMOL; PHENYTOIN; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; RIFAXIMIN; TUBERCULOSTATIC AGENT; UNINDEXED DRUG; VITAMIN K GROUP; ANALGESIC AGENT;

ACUTE KIDNEY FAILURE; ACUTE LIVER FAILURE; ANTIOXIDANT ACTIVITY; BLOOD CLOTTING DISORDER; BRAIN EDEMA; CLINICAL FEATURE; CONTINUOUS HEMODIALYSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG OVERDOSE; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HERPES SIMPLEX; HUMAN; HYPOTENSION; ILEUS; INFECTIOUS COMPLICATION; INTENSIVE CARE; INTESTINE DISTENSION; KIDNEY BLOOD FLOW; LIVER REGENERATION; LIVER SUPPORT; LIVER TOXICITY; LIVER TRANSPLANTATION; PATHOPHYSIOLOGY; PREGNANCY; PROGNOSIS; REVIEW; THERAPEUTIC HYPERVENTILATION; VIRUS PATHOGENESIS; FEMALE; HEPATITIS; LIVER FAILURE; MALE;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; BRAIN EDEMA; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; PREGNANCY; PROGNOSIS;

EID: 77954607560     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31673-4     Document Type: Review

References (24)

1. Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis 1970; 3: 282-298.
2. Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, McCashland TM, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.[see comment][summary for patients in Ann Intern Med. 2002 Dec 17;137(12):I24; PMID: 12484742]. Annals of Internal Medicine 2002; 137(12): 947-954.
3. Hoofnagle JH, Carithers RL, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology 1995; 21(1): 240-252.
4. Forde KA, Reddy KR, Troxel AB, Sanders CM, Lee WM. Racial and ethnic differences in presentation, etiology, and outcomes of acute liver failure in the United States. Clin Gastroenterol Hepatol 2009; 7(10): 1121-1126.
5. Polson LLW. AASLD Position Paper: the Management of Acute Liver Failure. Hepatology 2005; 41(5).
6. Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Da-vern T, Serrano J, Yang H, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008; 135(6): 1924-1934, 1934 e1-4.
7. Bogin V, Marcos A, Shaw-Stiffel T. In the eye of the beholder: evolving etiologies in acute liver failure. J Clin Gas-troenterol 2004. 38(8): 619-620.
8. Murray KF, Hadzic N, Wirth S.M. Bassett and D. Kelly, Drug-related hepatotoxicity and acute liver failure. J Pediatr Gastroenterol Nutr 2008; 47(4): 395-405.
9. Stravitz RT. Critical management decisions in patients with acute liver failure. Chest 2008; 134(5): 1092-1102.
10. Schilsky ML, Honiden S, Arnott L, Emre S, ICU management of acute liver failure. Clin Chest Med 2009; 30(1): 71-87, viii.
11. Fontana RJ. Acute liver failure including acetaminophen overdose. Med Clin North Am 2008; 92(4): 761-794, viii.
12. Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz R.T., Larson AM, Davern TJ, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-ace-taminophen acute liver failure. Gastroenterology 2009; 137(3): 856-864, 864 e1.
13. Karkhanis J, Lee WM, Brown RS. Steroid use in drug induced and cryptogenic causes of acute liver failure. AASLD Abstract 2008; 48(4): 446A-447A.
14. Butterworth RF. Role of circulating neurotoxins in the pa-thogenesis of hepatic encephalopathy: potential for improvement following their removal by liver assist devices. Liver Int 2003; 23(Suppl. 3): 5-9.
15. Davern TJ. Predicting prognosis in acute liver failure: Ammonia and the risk of cerebral edema. Hepatology 2007; 46(6): 1679-1681.
16. Sass DA, Shakil AO. Fulminant hepatic failure. Liver Trans-pl 2005; 11(6): 594-605.
17. Lidofsky SD, Bass NM, Prager MC, Washington DE, Read AE, Wright TL, Ascher NL, et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology 1992; 16(1): 1-7.
18. O'Grady JG. Acute liver failure. Postgrad Med J 2005; 81(953): 148-154.
19. Vaquero J, Blei AT. Mild hypothermia for acute liver failure: a review of mechanisms of action. J Clin Gastroenterol 2005; 39(4 Suppl. 2): S147-S157.
20. Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hy-pertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004; 39(2): 464-470.
21. Munoz SJ, Reddy RK, Lee W. The coagulopathy of acute liver failure and implications for intracranial pressure monitoring. Neurocrit Care 2008; 9(1): 103-107.
22. Stravitz RT, Kramer AH, Davern T, Shaikh AO, Caldwell SH, Mehta RL, Blei AT, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med 2007; 35(11): 2498-2508.
23. Hay JE. Liver disease in pregnancy. Hepatology 2008; 47(3): 1067-1076.
24. Blei AT. Selection for acute liver failure: have we got it right? Liver Transpl 2005; 11(11 Suppl. 2): S30-S34.